Apeloa Pharmaceutical Co.,Ltd (SHE:000739)
21.68
+0.35 (1.64%)
Aug 31, 2026, 3:04 PM CST
SHE:000739 Market Cap
SHE:000739 has a market cap or net worth of 24.01 billion as of August 31, 2026. Its market cap has increased by 31.50% in one year.
Market Cap
24.01B
Enterprise Value
22.49B
Revenue
9.16B
Ranking
n/a
PE Ratio
28.92
Stock Price
21.68
ChartMarket Cap Chart
Since January 2, 2001, SHE:000739's market cap has increased from 2.10B to 24.01B, an increase of 1,045.62%. That is a compound annual growth rate of 9.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 31, 2026 | 24.40B | 30.61% |
| Dec 31, 2025 | 18.68B | -0.80% |
| Dec 31, 2024 | 18.84B | 4.67% |
| Dec 29, 2023 | 18.00B | -28.65% |
| Dec 30, 2022 | 25.22B | -39.01% |
| Dec 31, 2021 | 41.35B | 50.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shijiazhuang Yiling Pharmaceutical | 27.03B |
| Zhejiang Huahai Pharmaceutical | 24.53B |
| Tianjin Pharmaceutical Da Ren Tang Group Corporation | 24.19B |
| Hubei Jumpcan Pharmaceutical | 23.09B |
| Walvax Biotechnology | 22.84B |
| Harbin Pharmaceutical Group | 22.67B |
| Jiangsu Nhwa Pharmaceutical Co., LTD | 22.39B |
| Tasly Pharmaceutical Group | 22.24B |